Tofacitinib for Treatment of Alopecia Areata: Real-world Evidence and Factors Associated with Therapeutic Response

Acta Derm Venereol. 2022 Jun 15:102:adv00736. doi: 10.2340/actadv.v102.2036.
No abstract available

MeSH terms

  • Alopecia / drug therapy
  • Alopecia Areata* / diagnosis
  • Alopecia Areata* / drug therapy
  • Humans
  • Piperidines / therapeutic use
  • Pyrimidines / adverse effects
  • Pyrroles / adverse effects

Substances

  • Piperidines
  • Pyrimidines
  • Pyrroles
  • tofacitinib

Supplementary concepts

  • Diffuse alopecia